Sofinnova News
Video: Sofinnova Partners 2024 annual general meeting
Related Strategy
CapitalRelated Strategy
CrossoverRelated Strategy
MD StartRelated Strategy
Digital MedicineRelated Strategy
Industrial BiotechRelated Strategy
TelethonRelated Strategy
BiovelocitaOur Annual General Meeting is a pivotal event that underscores the importance of collaboration and innovation in navigating our changing world, particularly in the current climate.
During this year's two-day event, our LPs, investment teams, and the CEOs of our portfolio companies shared stories of passion, perseverance, and the relentless pursuit of innovation to improve the health of people and the planet. These highlights remind us of the fundamentals we uphold in this period of constant change and uncertainty.
We extend our deepest gratitude to our LPs for their unwavering trust and support throughout the years. Their belief in our mission enables us to continue investing in groundbreaking science and innovation, which are essential in addressing our ever-changing world.
Check-out the video to get a glimpse of our 2024 Annual General Meeting:
Video of Sofinnova Partners 2024 Annual General Meeting
Related News
Sitryx appoints Adam Mostafa as Chief Financial Officer
TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization
Galvanize Therapeutics raises $100 million in oversubscribed Series C financing to transform the treatment of cancer and chronic lung disease
BrightHeart Sets New Standard in Prenatal CHD Screening with Landmark Study Published in Obstetrics & Gynecology
Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial